Short answer
ANI PHARMACEUTICALS INC (ANIP) filed an 8-K current report with the SEC on February 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 or full-year results reported by ANI Pharmaceuticals (ANIP), signed February 27, 2026: refer to accompanying exhibit for key figures.
ANI PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 or full-year results reported by ANI Pharmaceuticals (ANIP), signed February 27, 2026: refer to accompanying exhibit for key figures
- CFO Stephen P. Carey authorized the filing; actual financial results contained in the press release exhibit, not the filing body
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ANI PHARMACEUTICALS INC 8-K filings
Get the next ANIP 8-K as it lands
Follow ANIP for push alerts, or ask the research agent what this filing means.